{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:57:11Z","timestamp":1790373431772,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515140084"],"award-info":[{"award-number":["2023A1515140084"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470673"],"award-info":[{"award-number":["32470673"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["32470673"],"award-info":[{"award-number":["32470673"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"the 111 Project","award":["B16009"],"award-info":[{"award-number":["B16009"]}]},{"name":"the Construction Project of Liaoning Provincial Key Laboratory, China","award":["2022JH13\/10200026"],"award-info":[{"award-number":["2022JH13\/10200026"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and a leading cause of cancer-related mortality worldwide. Despite advances in targeted therapies and immunotherapies, clinical outcomes remain poor owing to profound molecular heterogeneity, intrinsic therapeutic resistance, and complex immune evasion mechanisms. Although genomic profiling has identified recurrent alterations in HCC, large-scale functional validation of candidate drivers and vulnerabilities remains challenging. CRISPR (clustered regularly interspaced short palindromic repeats)-based screening technologies have transformed this landscape by enabling systematic interrogation of gene function in physiologically relevant contexts. In this review, we summarize recent studies that have applied CRISPR screening approaches in HCC research. These efforts have uncovered multilayered dependency programs that govern ferroptosis resistance, metabolic reprogramming, epigenetic regulation, tumor suppressor networks, immune evasion, and resistance to targeted therapies. We also discuss the major limitations of current studies, including model bias, incomplete representation of HCC heterogeneity, and technical constraints intrinsic to pooled screening. Overall, integration of CRISPR screening with patient-derived models, single-cell readouts, and precision editing technologies is expected to accelerate mechanistic discovery and biomarker-guided therapeutic prioritization for HCC.<\/jats:p>","DOI":"10.3390\/ijms27104241","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:49:09Z","timestamp":1778572149000},"page":"4241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CRISPR Screening in Hepatocellular Carcinoma: From Tumor Progression to Immune Evasion and Therapeutic Resistance"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-3807","authenticated-orcid":false,"given":"Shixin","family":"Ma","sequence":"first","affiliation":[{"name":"Interdisciplinary Research Center for Brain-Computer Interface, Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China"},{"name":"Foshan Graduate School of Innovation, Northeastern University, Foshan 528311, China"},{"name":"National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China"},{"name":"Key Laboratory of Data Analytics and Optimization for Smart Industry, Northeastern University, Ministry of Education, Shenyang 110819, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-0730","authenticated-orcid":false,"given":"You","family":"Li","sequence":"additional","affiliation":[{"name":"Interdisciplinary Research Center for Brain-Computer Interface, Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China"},{"name":"Foshan Graduate School of Innovation, Northeastern University, Foshan 528311, China"},{"name":"National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China"},{"name":"Key Laboratory of Data Analytics and Optimization for Smart Industry, Northeastern University, Ministry of Education, Shenyang 110819, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-0450","authenticated-orcid":false,"given":"Teng","family":"Fei","sequence":"additional","affiliation":[{"name":"Interdisciplinary Research Center for Brain-Computer Interface, Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China"},{"name":"Foshan Graduate School of Innovation, Northeastern University, Foshan 528311, China"},{"name":"National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China"},{"name":"Key Laboratory of Data Analytics and Optimization for Smart Industry, Northeastern University, Ministry of Education, Shenyang 110819, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: Updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","article-title":"Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/s41467-018-07901-8","article-title":"Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities","volume":"9","author":"Sanson","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13982","DOI":"10.1073\/pnas.1512392112","article-title":"CRISPR\/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice","volume":"112","author":"Weber","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/hep.29626","article-title":"Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform","volume":"68","author":"Wangensteen","year":"2018","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2023.02.043","article-title":"A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23","volume":"164","author":"Saito","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41374-018-0027-6","article-title":"Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma","volume":"98","author":"Sun","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12964-025-02285-x","article-title":"In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling","volume":"23","author":"Tian","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41423-023-01048-3","article-title":"Elevated nuclear PIGL disrupts the cMyc\/BRD4 axis and improves PD-1 blockade therapy by dampening tumor immune evasion","volume":"20","author":"Yu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.18632\/oncotarget.27361","article-title":"CRISPR\/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma","volume":"10","author":"Zheng","year":"2019","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.7150\/ijbs.69969","article-title":"Genome-Wide CRISPR\/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma","volume":"18","author":"Huang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41420-021-00747-y","article-title":"Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance","volume":"7","author":"Lu","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41422-018-0020-z","article-title":"A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2019-318506","article-title":"CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1158\/0008-5472.CAN-21-1017","article-title":"A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41392-021-00713-1","article-title":"AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma","volume":"6","author":"Zhu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41575-021-00465-x","article-title":"Exploring liver cancer biology through functional genetic screens","volume":"18","author":"Wang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.crbiot.2023.100127","article-title":"CRISPR\/Cas9 genetic screens in hepatocellular carcinoma gene discovery","volume":"5","author":"Chiu","year":"2023","journal-title":"Curr. Res. Biotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.32604\/or.2023.044473","article-title":"A review of the literature on the use of CRISPR\/Cas9 gene therapy to treat hepatocellular carcinoma","volume":"32","author":"Amjad","year":"2024","journal-title":"Oncol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/HEP.0000000000000578","article-title":"Emerging and potential use of CRISPR in human liver disease","volume":"82","author":"Adlat","year":"2025","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/JHC.S456683","article-title":"CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma","volume":"11","author":"Palaz","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"aaf8729","DOI":"10.1126\/science.aaf8729","article-title":"Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems","volume":"353","author":"Nishida","year":"2016","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: Gene silencing through base-editing-induced nonsense mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2020.12.003","article-title":"Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk","volume":"108","author":"Jia","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.devcel.2017.12.003","article-title":"CRISPR Screens Uncover Genes that Regulate Target Cell Sensitivity to the Morphogen Sonic Hedgehog","volume":"44","author":"Pusapati","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acscentsci.4c01822","article-title":"A Pair of Fluorescent Probes Enabling Precise Diagnosis of Liver Cancer by Complementary Imaging","volume":"11","author":"Gao","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"eadw7181","DOI":"10.1126\/sciadv.adw7181","article-title":"Genome-wide CRISPR screen identifies splicing factor SF3B4 in driving hepatocellular carcinoma","volume":"11","author":"Guo","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Huang, Q., Wang, W., Ge, Q., Xu, D., Dong, R., Chang, R., Wu, X., Mo, J., Su, C., and Ning, D. (2025). NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma. Hepatology, publish ahead of print.","DOI":"10.1097\/HEP.0000000000001474"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e1758","DOI":"10.1002\/ctm2.1758","article-title":"High-fidelity CRISPR\/Cas12a dual-crRNA screening reveals novel synergistic interactions in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","article-title":"Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens","volume":"167","author":"Dixit","year":"2016","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nmeth.4177","article-title":"Pooled CRISPR screening with single-cell transcriptome readout","volume":"14","author":"Datlinger","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.cels.2024.12.002","article-title":"Multiome Perturb-seq unlocks scalable discovery of integrated perturbation effects on the transcriptome and epigenome","volume":"16","author":"Metzner","year":"2025","journal-title":"Cell Syst."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41592-019-0392-0","article-title":"Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells","volume":"16","author":"Mimitou","year":"2019","journal-title":"Nat. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1038\/s41467-026-69677-6","article-title":"Spatial perturb-seq: Single-cell functional genomics within intact tissue architecture","volume":"17","author":"Shen","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.1038\/srep08865","article-title":"A Dual-reporter system for real-time monitoring and high-throughput CRISPR\/Cas9 library screening of the hepatitis C virus","volume":"5","author":"Ren","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.celrep.2019.10.113","article-title":"A Genome-wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for Hepatitis B Surface Antigen Production","volume":"29","author":"Hyrina","year":"2019","journal-title":"Cell Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"eabd9732","DOI":"10.1126\/sciadv.abd9732","article-title":"TRIM26 is a critical host factor for HCV replication and contributes to host tropism","volume":"7","author":"Liang","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.6065","article-title":"TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"260","author":"Yang","year":"2023","journal-title":"J. Pathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"216935","DOI":"10.1016\/j.canlet.2024.216935","article-title":"CRISPR\/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma","volume":"593","author":"Yao","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2419625121","DOI":"10.1073\/pnas.2419625121","article-title":"Deciphering the role of the MALT1-RC3H1 axis in regulating GPX4 protein stability","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13046-024-03061-4","article-title":"PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1\/miR-195-5p axis-dependent manner in hepatocellular carcinoma","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1158\/0008-5472.CAN-24-4015","article-title":"The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular Carcinoma","volume":"85","author":"Liu","year":"2025","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41420-023-01630-8","article-title":"In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-\u03b3-induced ferroptosis of hepatocellular carcinoma","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"216405","DOI":"10.1016\/j.canlet.2023.216405","article-title":"Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy","volume":"576","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.drup.2023.101015","article-title":"CRISPR\/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS\/SOD1-dependent mitochondrial oxidative stress","volume":"71","author":"Lu","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2025.06.018","article-title":"Ferredoxin 1-like maintains iron homeostasis and hepatoma cell survival","volume":"238","author":"Zheng","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1186\/s12967-025-07161-3","article-title":"KBTBD11 suppresses hepatocellular carcinoma by targeting ENO1-mediated glycolysis","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.devcel.2024.12.035","article-title":"DYRK1A-TGF-\u03b2 signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma","volume":"60","author":"Cao","year":"2025","journal-title":"Dev. Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"104397","DOI":"10.1016\/j.ebiom.2022.104397","article-title":"Sustained activation of EGFR-ERK1\/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer","volume":"87","author":"Zhou","year":"2023","journal-title":"EBioMedicine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/gutjnl-2024-334630","article-title":"High-protein diets alleviate tumour growth and drug resistance by promoting AKT aggregation and turnover","volume":"74","author":"Bu","year":"2025","journal-title":"Gut"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41418-024-01323-4","article-title":"The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine","volume":"31","author":"Shi","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1080\/15548627.2024.2358732","article-title":"TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/15548627.2024.2406186","article-title":"ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms","volume":"21","author":"Xu","year":"2024","journal-title":"Autophagy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/15548627.2022.2117893","article-title":"Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma","volume":"19","author":"Pan","year":"2023","journal-title":"Autophagy"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13046-025-03386-8","article-title":"Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: Clinical implications","volume":"44","author":"Zhao","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101502","DOI":"10.1016\/j.jcmgh.2025.101502","article-title":"Genome-wide CRISPR Screening Identifies NF\u03baB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular Carcinoma","volume":"19","author":"Wan","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s13402-025-01097-y","article-title":"PTEN loss and ERBB2\/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinoma","volume":"48","author":"Qian","year":"2025","journal-title":"Cell. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"114389","DOI":"10.1016\/j.yexcr.2024.114389","article-title":"Targeting METTL8 with Rabdosiin overcomes lenvatinib resistance in hepatocellular carcinoma","volume":"444","author":"Liu","year":"2025","journal-title":"Exp. Cell Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"210","DOI":"10.14740\/wjon2514","article-title":"Comprehensive Investigation of a Tyrosine Kinase Inhibitor-Resistant Gene Zeste White 10 in Hepatocellular Carcinoma","volume":"16","author":"Huang","year":"2025","journal-title":"World J. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e2416360","DOI":"10.1002\/advs.202416360","article-title":"COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma","volume":"12","author":"Luo","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e2402327","DOI":"10.1002\/advs.202402327","article-title":"Stabilization of TGF-\u03b2 Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-\u03b2 Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3350\/cmh.2025.0972","article-title":"ERBB3 blockade sensitizes HCC to regorafenib after first-line TKI resistance by inhibiting HIF1A-ABCB1 signaling","volume":"32","author":"Tao","year":"2026","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/CAD.0000000000001775","article-title":"A genome-wide screen identified ARHGAP35 as a regulator of regorafenib resistance in liver cancer","volume":"37","author":"Chen","year":"2026","journal-title":"Anticancer Drugs"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s42003-026-09722-8","article-title":"CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy","volume":"9","author":"Hu","year":"2026","journal-title":"Commun. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1038\/s41467-023-41593-z","article-title":"SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e168375","DOI":"10.1172\/jci.insight.168375","article-title":"SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e00335","DOI":"10.1002\/advs.202500335","article-title":"RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53(R249S) Mutation and is a Potential Therapeutic Target","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"106099","DOI":"10.1016\/j.isci.2023.106099","article-title":"CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasis","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1038\/s41467-025-62743-5","article-title":"CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL\/RPS transcription","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"112065","DOI":"10.1016\/j.celrep.2023.112065","article-title":"Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"eadh1442","DOI":"10.1126\/sciadv.adh1442","article-title":"Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer","volume":"9","author":"Huth","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"101460","DOI":"10.1016\/j.jcmgh.2025.101460","article-title":"In Vivo CRISPR Activation Screening Reveals Chromosome 1q Genes VPS72, GBA1, and MRPL9 Drive Hepatocellular Carcinoma","volume":"19","author":"Cai","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Xu, Y., Mishra, H., Furutani, Y., Yanaka, K., Nishimura, H., Furuhata, E., Takahashi, M., Gailhouste, L., Suenaga, Y., and Hippo, Y. (2025). A high-throughput screening platform to identify MYCN expression inhibitors for liver cancer therapy. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1486671"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gutjnl-2024-332902","article-title":"Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC","volume":"74","author":"Chen","year":"2024","journal-title":"Gut"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-025-02319-5","article-title":"BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma","volume":"24","author":"Fu","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2025.01.027","article-title":"Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity","volume":"83","author":"Zhang","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e009642","DOI":"10.1136\/jitc-2024-009642","article-title":"Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma","volume":"12","author":"Zheng","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e0256","DOI":"10.1097\/HC9.0000000000000256","article-title":"In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin-like growth factor 2 mRNA-binding protein 1 in hepatocellular carcinoma","volume":"7","author":"Peng","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"eadk2285","DOI":"10.1126\/sciadv.adk2285","article-title":"Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis","volume":"10","author":"Gao","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"116619","DOI":"10.1016\/j.celrep.2025.116619","article-title":"Menin-MLL1 complex cooperates with NF-Y to promote hepatocellular carcinoma survival","volume":"44","author":"Sokolowski","year":"2025","journal-title":"Cell Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41419-023-06046-x","article-title":"CRISPR screen identifies the role of RBBP8 in mediating unfolded protein response induced liver damage through regulating protein synthesis","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.cell.2016.11.048","article-title":"A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response","volume":"167","author":"Adamson","year":"2016","journal-title":"Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.aax4438","article-title":"Exploring genetic interaction manifolds constructed from rich single-cell phenotypes","volume":"365","author":"Norman","year":"2019","journal-title":"Science"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41588-021-00779-1","article-title":"Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion","volume":"53","author":"Frangieh","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2021.01.012","article-title":"Massively parallel assessment of human variants with base editor screens","volume":"184","author":"Hanna","year":"2021","journal-title":"Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2020.05.037","article-title":"Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning","volume":"182","author":"Arbab","year":"2020","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","article-title":"Predicting the efficiency of prime editing guide RNAs in human cells","volume":"39","author":"Kim","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:11:39Z","timestamp":1779250299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":115,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104241"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104241","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]}}}